Immunotherapy, particularly ICIs, shows potential in treating certain STS subtypes, but efficacy varies and requires further investigation. Blood-based biomarkers, including neutrophil-to-lymphocyte ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — A novel T-cell receptor therapy showed promising antitumor activity in patients with advanced soft ...

Editor’s Note: The Vail Daily’s Tricia Swenson searched the valley for alternative wellness modalities that are lesser-known and have proven benefits. Follow this series and take steps to improve your ...

Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...

Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparable tumor ...

Adding Opdivo and Yervoy to Cabometyx led to improved progression-free survival and disease control rates in patients with soft tissue sarcoma, recent research showed. Combining Cabometyx ...

Adaptimmune has won accelerated FDA approval for Tecelra (afami-cel), a treatment for metastatic or unresectable synovial sarcoma. Tecelra’s approval comes with several firsts. It’s the first ...

Soft tissue sarcoma recovery extends beyond physical healing, emphasizing social engagement and emotional well-being for improved quality of life. Pain and daily activity participation are major ...

A soft tissue sarcoma (STS) is a malignant tumor that starts in soft tissue such as muscle, deep skin tissues, cartilage, or fat. It often occurs as a lump in the arm, although it can happen anywhere.